SCHEMBL968609

SCHEMBL968609

O=C(CN1CCc2c([nH]c3ccccc23)C1)N1CCN2CCCCC2C1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 4/20 0.58
ALDH1A1 P00352 3/20 0.58
KDM4E B2RXH2 2/20 0.58
HPGD P15428 1/20 0.58
CASP1 P29466 2/20 0.49
CASP7 P55210 2/20 0.49
GPX4 P36969 1/20 0.49
HTR1A P08908 1/20 0.49
DRD2 P14416 1/20 0.49
ADRA1D P25100 1/20 0.49
ADRA1A P35348 1/20 0.49
ADRA1B P35368 1/20 0.49
MEN1 O00255 1/20 0.48
ALOX15 P16050 1/20 0.48
KMT2A Q03164 1/20 0.48
PRMT5 O14744 3/20 0.48
WDR77 Q9BQA1 3/20 0.48
GRIN2B Q13224 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL969739 0.94 ALDH1A1 (0.60) PARP1ALDH1A1KDM4EHPGDCASP1
SCHEMBL969089 0.92 PARP1 (0.65) PARP1ALDH1A1KDM4EHPGDCASP1
SCHEMBL968434 0.91 ALDH1A1 (0.64) PARP1ALDH1A1KDM4EHPGDCASP1
SCHEMBL970324 0.91 ALDH1A1 (0.64) PARP1ALDH1A1KDM4EHPGDCASP1
SCHEMBL967118 0.90 ALDH1A1 (0.63) PARP1ALDH1A1KDM4EHPGDCASP1
SCHEMBL968213 0.88 ALDH1A1 (0.66) PARP1ALDH1A1KDM4EHPGDCASP1
SCHEMBL968427 0.87 ALDH1A1 (0.67) PARP1ALDH1A1KDM4EHPGDCASP1
SCHEMBL12920006 0.85 ALDH1A1 (0.56) PARP1ALDH1A1KDM4EHPGDCASP1
SCHEMBL968014 0.84 ALDH1A1 (0.57) PARP1ALDH1A1KDM4EHPGDCASP1
SCHEMBL971057 0.82 ALDH1A1 (0.59) PARP1ALDH1A1KDM4EHPGDCASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US claimed
EP-2162451-A2 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES Neurogen Corporation (US) 2010-03-17 EP claimed
WO-2009003003-A2 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2008-12-31 WO claimed
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US disclosed
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US disclosed
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2011-01-06 US disclosed
WO-2009003003-A2 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2008-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110002855-A1 PIPERAZINYL OXOALKYL TETRAHYDRO-BETA-CARBOLINES AND RELATED ANALOGUES HRH3, HRH4, HRH1 PARP1 2898/4885ALDH1A1 812/4885KDM4E 3037/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.